Intellectual Property Waiver for COVID Vaccines | Daily Current Affairs 2021

Intellectual Property Waiver for COVID Vaccines

Posted by
Subscribe for News Feed

U.S. President Joe Biden’s administration recently announced its support for waiving intellectual property protections for COVID-19 vaccines.

  • The US will further negotiate with the World Trade Organization to waive Intellectual property for COVID-19 vaccines.
  • This will help in the large-scale production of COVID-19 vaccines in middle-income countries.


  • Earlier this month, India and South Africa have submitted a proposal suggesting a waiver for all WTO members on the implementation, application and enforcement of certain provisions of the TRIPS Agreement in relation to the prevention, containment or treatment of COVID-19.
  • Regarding this, as many as 40 members of the Geneva-based World Trade Organization (WTO) have discussed a proposal submitted by India and South Africa for relaxing certain provisions in intellectual property (IP) agreement with a view to contain the COVID-19 pandemic.

Current Scenario:

  • 100 countries of the 164 members are in favour of waiving the IP.
  • Recently Australia and New Zealand also agreed on the waiver.

About Intellectual Property Waiver for COVID-19 vaccine:

  • IP right is a monopoly granted by a government to an inventor.
  • It means that the others cannot copy their invention.
  • It can be a process patent or a product patent.
  • The developing countries are arguing that intellectual property is an obstacle in increasing the production of vaccines.
  • The production of COVID-19 vaccines in middle-income countries has been happening through licensing or technology transfer agreements. Therefore, in order to ramp up the production of the COVID-19 vaccine production, it is essential to waive off (remove) the Intellectual Property Rights for the COVID-19 vaccine.
  • In simple terms, an IPR waiver means that when a company has produced a vaccine, the others can immediately copy its composition produce their own. This will increase vaccine production and decrease vaccine costs.

Subscribe for News Feed